不孕症治疗与儿童期哮喘及特应性疾病的关联
Upstate KIDS前瞻性队列纳入5034名母亲和6171名儿童,随访至2019年,2056名儿童参与中期随访。与未治疗者相比,接受不孕症治疗的儿童3岁前持续喘息风险升高(RR 1.66),7-9岁时湿疹(RR 1.77)和过敏相关药物处方(RR 1.45)风险升高,当前哮喘风险为RR 1.30(95%CI 0.98-1.71)。
要点
- 接受不孕症治疗的儿童3岁前持续喘息风险较未治疗者升高(RR 1.66,95%CI 1.17-2.33)。
- 7-9岁时湿疹风险升高(RR 1.77,95%CI 1.25-2.49),过敏相关药物处方风险升高(RR 1.45,95%CI 1.06-1.99)。
- 7-9岁时当前哮喘风险为RR 1.30(95%CI 0.98-1.71),未达统计学显著。
核心结论
- 不孕症治疗与子代早期和中期儿童期哮喘及特应性条件风险升高相关,即使调整父母哮喘和特应性后仍存在。
- 作者认为未来研究需阐明相关机制,但研究结果支持ART和OI/IUI均从早期影响子代哮喘和特应性疾病的发生。
研究设计与样本
- Upstate KIDS为前瞻性队列研究,纳入2008年至2010年出生的单胎和多胎。
- 共5034名母亲和6171名儿童入组并随访至2019年,2056名儿童参与中期儿童期随访。
- 母亲在基线问卷报告助孕药物,治疗分为ART(约22%)、口服/注射药物诱导排卵伴或不伴IUI(OI/IUI,约20%)或未治疗(约58%)。
- 结局通过母亲问卷报告评估,早期儿童期(至3岁,患病率9-28%)和中期儿童期(7-9岁,患病率10-16%)。
- 采用加权泊松回归模型及稳健标准误分析不孕症治疗暴露与特应性结局风险。
主要发现
- 与未治疗者相比,接受任何不孕症治疗的儿童3岁前持续喘息风险升高(RR 1.66;95%CI 1.17,2.33),已调整父母特应性及其他危险因素。
- 7-9岁时,接受治疗的儿童当前哮喘风险为RR 1.30(95%CI 0.98,1.71),未达统计学显著。
- 7-9岁时,接受治疗的儿童湿疹风险升高(RR 1.77;95%CI 1.25,2.49)。
- 7-9岁时,接受治疗的儿童被处方过敏相关药物的风险升高(RR 1.45;95%CI 1.06,1.99)。
- 按治疗类型(ART vs OI/IUI)分析时发现相似效应量。
临床怎么用
- 原文未据此给出推荐。
局限性
- 儿童期结局基于母亲报告,可能存在错分类。
- 本研究存在失访,限制了关联测量的精确性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
STUDY QUESTION: Are children who were conceived with infertility treatment at an increased risk of developing asthma and atopic conditions? SUMMARY ANSWER: Infertility treatment is associated with an elevated risk of asthma and atopic conditions in early and middle childhood, even after adjustment for parental asthma and atopy. WHAT IS KNOWN ALREADY: Asthma and atopic conditions are prevalent in childhood. The development of these conditions may be linked to early life exposures, including the use of infertility treatments. STUDY DESIGN, SIZE, DURATION: Upstate KIDS is a prospective cohort study of singletons and multiples born between 2008 and 2010. A total of 5034 mothers and 6171 children were enrolled and followed up until 2019, and 2056 children participated in the middle childhood follow-up. PARTICIPANTS/MATERIALS, SETTING, METHODS: Women reported the fertility agents used to become pregnant on a baseline questionnaire. Treatment was categorized as ART (∼22%) use, ovulation induction via oral/injectable medications with or without IUI (OI/IUI, ∼20%), or no treatment (∼58%). Outcomes were assessed by maternal report on questionnaires in early (up to age 3 years, prevalence 9-28%) and middle (7-9 years, prevalence 10-16%) childhood. Weighted Poisson regression models with robust standard errors were used to analyze the risk of atopic outcomes in relation to infertility treatment exposure. MAIN RESULTS AND THE ROLE OF CHANCE: Compared to children conceived without treatment, children conceived with any infertility treatment were at an increased risk of persistent wheeze by age 3 years (relative risk (RR): 1.66; 95% CI: 1.17, 2.33) with adjustments for parental atopy among other risk factors. Around 7-9 years, children conceived with treatment were more likely to have current asthma (RR: 1.30; 95% CI: 0.98, 1.71), eczema (RR: 1.77; 95% CI: 1.25, 2.49) or be prescribed allergy-related medications (RR: 1.45; 95% CI: 1.06, 1.99). Similar effect sizes were found when examining associations by treatment type (i.e. ART versus OI/IUI). LIMITATIONS, REASONS FOR CAUTION: Childhood outcomes were based on maternal report and are subject to potential misclassification. There was attrition in this study, which limits the precision of our measures of association. WIDER IMPLICATIONS OF THE FINDINGS: Though future research is needed to clarify the mechanisms involved, our findings support that both ART and OI/IUI influences the development of asthma and atopic conditions in the offspring from an early age. STUDY FUNDING/COMPETING INTEREST(S): This work was supported by the National Institutes of Health's Intramural Research Program at the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD; contracts #HHSN275201200005C, #HHSN267200700019C, #HHSN275201400013C, #HHSN275201300026I/27500004, #HHSN275201300023I/27500017). The authors have no relevant conflicts of interest to disclose. TRIAL REGISTRATION NUMBER: N/A.
引用
- Polinski KJ, Stevens DR, Mendola P, et al. Infertility treatment associated with childhood asthma and atopy. Hum Reprod. 2022. PMID: 35446387. doi:10.1093/humrep/deac070
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。